Tamsulosin Hydrochloride Capsule
Product Images NDC 67877-450

8 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67877-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Tamsulosin-structure (Tamsulosin Structure)
Chemical structure of tamsulosin hydrochloride, showing its molecular configuration with distinct aromatic rings, functional groups such as methoxy, sulfonamide, and hydrochloride salt representation.*
FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

Tamsulosin-figure1 (Tamsulosin Figure1)
A line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) comparing fasted and fed states. The y-axis represents plasma concentration, and the x-axis represents time up to 36 hours. The fasted state curve peaks higher and earlier than the fed state curve.*
FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

Tamsu-fi2a (Tamsulosin Figure2a)
A line graph showing mean change over weeks of treatment comparing three groups: 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment duration in weeks, and the y-axis shows mean change. The graph includes sample sizes for each time point and indicates measurement at last observation carried forward (LOCF).*
FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

Tamsu-fig2b (Tamsulosin Figure2b)
A line graph showing mean change over the duration of treatment in weeks for different dosages of Tamsulosin Hydrochloride (.4 mg and 0.8 mg) compared to placebo. The x-axis represents weeks of treatment, and the y-axis represents mean change, illustrating the treatment effects over time.*
FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

Tamsu-fig3a (Tamsulosin Figure3a)
A line graph depicting mean change over time in mL/sec for treatments of Tamsulosin Hydrochloride at 0.8 mg and 0.4 mg doses compared to placebo. The x-axis represents treatment duration in weeks up to 13, and the y-axis shows mean change values. Data points for each group are plotted with distinct markers and connected by dashed lines.*
FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

Tamsu-fig3b (Tamsulosin Figure3b)
Line graph depicting mean change in mL/sec over weeks of treatment for three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis shows duration of treatment in weeks, while the y-axis represents mean change in mL/sec. Different line styles and markers distinguish the treatment groups.*
FDA Label Image

Container Label (Tamsulosin 100s 1a)

Container Label (Tamsulosin 100s 1a)
Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg, an oral prescription drug. The label indicates a package of 100 capsules, distributed by Ascend Laboratories, LLC. It includes storage instructions, dosage guidance, and manufacturer information (Alkem Laboratories Ltd., Mumbai, India). A barcode and NDC 67877-450-01 are also visible.*
FDA Label Image

Container Label2 (Tamsulosin 0 4mg 500)

Container Label2 (Tamsulosin 0 4mg 500)
Tamsulosin Hydrochloride Capsules, USP 0.4 mg, oral capsules by Ascend Laboratories, LLC. The label shows 500 capsules per container, with storage instructions, dosage note, and manufacturer details (Alkem Laboratories Ltd., India). The label includes the NDC 67877-450-05 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.